Skip to content

Assessment of maternal and placental oxidative & nitrosative stress and inflammatory markers in maternal obesity with and without preeclampsia

Assessment of maternal and placental oxidative & nitrosative stress and inflammatory markers in maternal obesity with and without preeclampsia

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240318002
Enrollment
80
Registered
2024-03-18
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women age between 20-39 year. Volunteers are lean pregnant women with preeclampsia and without preeclampsia and obese pregnant women which will be sub-divided into two groups including uncomplicated maternal obesity and preeclamptic maternal obesity. Maternal obesity, oxidative stress, antioxidant, inflammation, placenta

Interventions

Pregnant women whose BMI before pregnancy was within the normal range, No preeclampsia. ,Pregnant women who have a pre-pregnancy BMI higher than normal and do not have preeclampsia.,Pregnant women who
Uncomplicated lean group (Control group),Uncomplicated obesity group,Preeclamptic lean group,Preeclamptic obesity group

Sponsors

Khon Kaen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women were divided into four groups including preeclamptic obesity group, preeclamptic lean, uncomplicated obesity, and uncomplicated lean. 2. Singleton pregnancy 3. Normal vaginal delivery or cesarean delivery 4. No history of smoking, alcoholism, or exposure to teratogenic substances 5. No history of chronic diseases including chronic hypertension, diabetes mellitus, kidney, liver, immune and respiratory diseases, infections, and fetal anomalies

Exclusion criteria

Exclusion criteria: 1) Newborn abnormalities 2) Low birth weight (defined as birth weight below 1000 g) 3) Obstetric complications during delivery and postpartum including uterine rupture retained placenta and postpartum hemorrhage

Design outcomes

Primary

MeasureTime frame
Biomarker Placenta tissue, Maternal blood and umbilical cord blood, collected immediately after delivery, and biomarker analysis Biochemical assessment

Secondary

MeasureTime frame
Anthropometric data Anthropometric data were collected from volunteers during the postpartum recovery period while they were admitted to the hospital ward. questionaire

Countries

Thailand

Contacts

Public ContactSophida Phuthong

FACULTY OF MEDICINE, KHON KAEN UNIVERSITY

sophiph@kku.ac.th0973919163

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026